TLX3 and neoplasm: It has been reported that Phf6 loss could significantly accelerate T-ALL development driven by co-mutation with JAK3M511I or with aberrant expression of TLX3, suggesting PHF6 as a tumor suppressor in T-ALL [21, 23].